Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on ...
Eligibility criteria for OAG/OHT study eyes include C/D ratio ≤ 0.8, visual field mean deviation ≥ −12 dB, BCVA 20/80 or better, and specific IOP requirements. Exclusions involve prior glaucoma surgeries, ocular conditions affecting measurements, and systemic diseases. Procedures include informed consent, ophthalmic assessments, and randomization to FE/SE implants or sham. Follow-up visits assess IOP, visual acuity, and adverse events. Statistical analysis aims to confirm non-inferiority of implant effects on IOP reduction.
Highlighted Terms
Related News
Eligibility criteria for OAG/OHT study eyes include C/D ratio ≤ 0.8, visual field mean deviation ≥ −12 dB, BCVA 20/80 or better, and specific IOP requirements. Exclusions involve prior glaucoma surgeries, ocular conditions affecting measurements, and systemic diseases. Procedures include informed consent, ophthalmic assessments, and randomization to FE/SE implants or sham. Follow-up visits assess IOP, visual acuity, and adverse events. Statistical analysis aims to confirm non-inferiority of implant effects on IOP reduction.